The frequency of KRAS mutation has been reported to be associated with age, gender, differentiation and tumor stage (Gao et al., 2012; Li et al., 2011; Ye et al., 2015; Yunxia et al., 2010; Zhu et al., 2012). Here, KRAS is linked to neoplasm.